Z79.62 Kategorie · weitere Spezifizierung erforderlich Long term (current) use of immunosuppressant
ICD-10-CM Z79.62 identifies “Long term (current) use of immunosuppressant” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 21: Factors influencing health status and contact with health services
Hinweise zum Code
Keine zusätzlichen Hinweise.
Hinweise übergeordneter Ebenen
Kapitel 21 · Factors influencing health status and contact with health services (Z00-Z99)
Note3
- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Z77-Z99 · Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Code also1
any follow-up examination (Z08-Z09)
Z79 · Long term (current) drug therapy
Includes1
long term (current) drug use for prophylactic purposes
Excludes 22
- drug abuse and dependence (F11-F19)
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Code also1
any therapeutic drug level monitoring (Z51.81)
Z79.6 · Long term (current) use of immunomodulators and immunosuppressants
Spezifischere Codes
Z79.620Long term (current) use of immunosuppressive biologicAbrechenbarer, spezifischer CodeZ79.621Long term (current) use of calcineurin inhibitorAbrechenbarer, spezifischer CodeZ79.622Long term (current) use of Janus kinase inhibitorAbrechenbarer, spezifischer CodeZ79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitorAbrechenbarer, spezifischer CodeZ79.624Long term (current) use of inhibitors of nucleotide synthesisAbrechenbarer, spezifischer CodeVerweise im offiziellen Index
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2023
GeändertUnverändert
FY2023
Gültig ab
- Hinzugefügt
Long term (current) use of immunosuppressant
Kategorie — spezifischeren Code auswählen
CDC/NCHS · FY2023Alle Ausgaben (9)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2023 | 2022-10-01 | Hinzugefügt |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Entdecken Sie die spezifischeren Codes dieser Kategorie. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.